Skip to content
healthcare.dev

NUZOLVENCE

NDC 68547-915, zoliflodacin, for suspension, from La Jolla Pharmaceutical Company.

Product NDC
68547-915
Status
Listed
Labeler
La Jolla Pharmaceutical Company
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68547-915 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZOLIFLODACIN3 g/1
Package NDCNDC-11Package
68547-915-10685470915101 PACKET in 1 CARTON (68547-915-10) / 1 FOR SUSPENSION in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4beda35a-21b0-4b34-84ea-be6ea8cae50f

Use it

Look up 68547-915 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68547-915 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68547-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.